Gobbi C, et al. Real-world data from the TACO (teriflunomide in relapsing remitting multiple sclerosis patients assessing clinical benefit and patient-reported outcomes) study. Poster 1371. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Cognitieve therapie helpt patiënten met myotone dystrofie type 1
okt 2018 | Neuro-musculair